News
Glenmark Pharma shares hit upper circuit limit after signing a USD 2 billion deal with AbbVie for a cancer drug. Stock hits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback